Statin monotherapy is generally well tolerated, with a low frequency of adverse events. The most important adverse effects associated with statins are myopathy and an asymptomatic increase in hepatic transaminases, both of which occur infrequently. Because statins are prescribed on a long-term basis, however, possible interactions with other drugs deserve particular attention, as many patients will typically receive pharmacological therapy for concomitant conditions during the course of statin treatment. This review summarizes the pharmacokinetic properties of statins and emphasizes their clinically relevant drug interactions.

Safety of statins: focus on clinical pharmacokinetics and drug interactions / S. Bellosta, R. Paoletti, A. Corsini. - In: CIRCULATION. - ISSN 0009-7322. - 109:23 (Suppl. 1)(2004 Jun 15), pp. III-50-III-57.

Safety of statins: focus on clinical pharmacokinetics and drug interactions

S. Bellosta
Primo
;
R. Paoletti
Secondo
;
A. Corsini
Ultimo
2004

Abstract

Statin monotherapy is generally well tolerated, with a low frequency of adverse events. The most important adverse effects associated with statins are myopathy and an asymptomatic increase in hepatic transaminases, both of which occur infrequently. Because statins are prescribed on a long-term basis, however, possible interactions with other drugs deserve particular attention, as many patients will typically receive pharmacological therapy for concomitant conditions during the course of statin treatment. This review summarizes the pharmacokinetic properties of statins and emphasizes their clinically relevant drug interactions.
English
Drug interactions; Fibrates; Rhabdomyolysis; Safety; Statins
Settore BIO/14 - Farmacologia
Articolo
Esperti anonimi
15-giu-2004
Lippincott Williams & Wilkins
109
23 (Suppl. 1)
III-50
III-57
Pubblicato
Periodico con rilevanza internazionale
info:eu-repo/semantics/article
Safety of statins: focus on clinical pharmacokinetics and drug interactions / S. Bellosta, R. Paoletti, A. Corsini. - In: CIRCULATION. - ISSN 0009-7322. - 109:23 (Suppl. 1)(2004 Jun 15), pp. III-50-III-57.
open
Prodotti della ricerca::01 - Articolo su periodico
3
262
Article (author)
si
S. Bellosta, R. Paoletti, A. Corsini
File in questo prodotto:
File Dimensione Formato  
2004 Circulation Safety of statins.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 331.52 kB
Formato Adobe PDF
331.52 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/143653
Citazioni
  • ???jsp.display-item.citation.pmc??? 184
  • Scopus 601
  • ???jsp.display-item.citation.isi??? 504
  • OpenAlex ND
social impact